Epigenetic control of immunoevasion in cancer stem cells
Trends in Cancer · 2024
DOI: 10.1016/j.trecan.2024.08.004 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Trends in Cancer, 2024. Verfasst von Claudia Galassi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Weill Cornell Medical College, New York, NY, USA. Hauptthemen laut MEDLINE: Neoplastic Stem Cells, Epigenesis, Genetic, Neoplasms, Histones. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 224 Literaturangaben. Gefördert von: NCI NIH HHS, Fundación Cellex, AstraZeneca.
Abstract (Originalsprache)
Cancer stem cells (CSCs) are a poorly differentiated population of malignant cells that (at least in some neoplasms) is responsible for tumor progression, resistance to therapy, and disease relapse. According to a widely accepted model, all stages of cancer progression involve the ability of neoplastic cells to evade recognition or elimination by the host immune system. In line with this notion, CSCs are not only able to cope with environmental and therapy-elicited stress better than their more differentiated counterparts but also appear to better evade tumor-targeting immune responses. We summarize epigenetic modifications of DNA and histones through which CSCs evade immune recognition or elimination, and propose that such alterations constitute promising therapeutic targets to increase the sensitivity of some malignancies to immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiation Oncology, Weill Cornell Medical College, New York, NY, USA.
- Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Barcelona, Spain; Centro de Investigacion Biomedica en Red Cancer (CIBERONC), Madrid, Spain; Institució Catalana de Recerca i Estudis Avançats…
- Italian Institute for Genomic Medicine, Istituto di Ricovero e Cura a Carattere Scientifico (IRCSS) Candiolo, Torino, Italy; Candiolo Cancer Institute, FPO - IRCCS, Candiolo, Italy. Electronic address: iliovit@gmail.com.
- Department of Radiation Oncology, Weill Cornell Medical College, New York, NY, USA; Sandra and Edward Meyer Cancer Center, New York, NY, USA; Caryl and Israel Englander Institute for Precision Medicine, New York, NY, US…
Förderung
- NCI NIH HHS
- Fundación Cellex
- AstraZeneca
- Leukemia and Lymphoma Society
- American-Italian Cancer Foundation
- National Institutes of Health
- Generalitat de Catalunya
- Weill Cornell Medicine
Zitieren
APA
Galassi, C., Esteller, M., Vitale, I., & Galluzzi, L. (2024). Epigenetic control of immunoevasion in cancer stem cells. Trends in Cancer. https://doi.org/10.1016/j.trecan.2024.08.004
Vancouver
Galassi C, Esteller M, Vitale I, Galluzzi L. Epigenetic control of immunoevasion in cancer stem cells. Trends in Cancer. 2024. doi:10.1016/j.trecan.2024.08.004
BibTeX
@article{Galassi2024,
author = {Galassi, Claudia and Esteller, Manel and Vitale, Ilio and Galluzzi, Lorenzo},
title = {Epigenetic control of immunoevasion in cancer stem cells},
journal = {Trends in Cancer},
year = {2024},
doi = {10.1016/j.trecan.2024.08.004}
}
EUVIMED